Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
32
Number of overlapping holdings
64.0%
% of FTXH's 51 holdings also in XBI
24.1%
% of XBI's 134 holdings also in FTXH
Overlap by Weight
Sector Drift (FTXH minus XBI)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in FTXH |
Weight in XBI |
Overlap | |
|---|---|---|---|---|
 |
ABBVIE INC | 7.2% | 2.5% | 2.5% |
|
GILEAD SCIENCES INC | 4.7% | 2.5% | 2.5% |
|
AMGEN INC | 3.3% | 2.4% | 2.4% |
|
UNITED THERAPEUTICS CORP | 3.6% | 2.3% | 2.3% |
|
BIOGEN IDEC INC | 2.7% | 2.1% | 2.1% |
Position Highlights (Non-Overlapping Exposures)
FTXH Overweight Relative to XBI
|
BRISTOL-MYERS SQUIBB CO | 9.0% |
|
JOHNSON & JOHNSON | 7.0% |
|
PFIZER INC | 7.0% |
|
MERCK & CO. INC. | 6.4% |
|
ABBVIE INC | 4.7% |
|
CARDINAL HEALTH INC | 4.2% |
|
VIATRIS, INC. | 3.6% |
|
ZOETIS INC | 3.6% |
 |
JAZZ PHARMACEUTICALS PLC | 3.5% |
|
ELI LILLY & CO | 3.2% |
FTXH Underweight Relative to XBI
|
NATERA INC | -2.5% |
|
VAXCYTE, INC. | -2.3% |
|
MODERNA, INC. | -2.1% |
|
MADRIGAL PHARMACEUTICALS, INC. | -1.9% |
|
INSMED INC | -1.9% |
|
BIOMARIN PHARMACEUTICAL INC | -1.8% |
|
VERTEX PHARMACEUTICALS INC | -1.8% |
|
ALNYLAM PHARMACEUTICALS INC | -1.8% |
|
INCYTE CORP | -1.8% |
|
SAREPTA THERAPEUTICS INC | -1.7% |